Tislelizumab
Sanofi, Earendil Labs ink up to US$ 2.56 bn AI-driven autoimmune drug deal; CDC revises childhood immunization guidelines

Sanofi, Earendil Labs ink up to US$ 2.56 bn AI-driven autoimmune drug deal; CDC revises childhood immunization guidelines

The New Year began with two mid-size deals centered around the use of artificial intelligence (AI) in drug development. Sanofi...

Impressions : 1525

Madrigal’s Rezdiffra becomes first FDA-approved drug to treat NASH; Astra buys Fusion for US$ 2.4 bn

Madrigal’s Rezdiffra becomes first FDA-approved drug to treat NASH; Astra buys Fusion for US$ 2.4 bn

It was a week of drug approvals, as the US Food and Drug Administration (FDA) okayed several therapies before the close of the...

Impressions : 3061

Pfizer’s oral Covid drug bags authorization in US; Biogen slashes price of its Alzheimer’s drug by half

In this week’s Phispers, we bring you updates on Biogen’s controversial Alzheimer’s drug, Novartis’ pla...

Impressions : 1890

White House unveils plans to roll out jabs for 5 to 11 year olds; FDA authorizes Moderna, J&J boosters

This week, Phispers has more updates on Covid vaccines and boosters. Novavax’s Covid-19 vaccine program may have hit a br...

Impressions : 1759